Source for all information in this report is from the Legislative Budget Board documents.
Funding included in both houses for the Department of State Health Services (DSHS) for the 2022–23 biennium totals $1.8 billion in All Funds, including $0.5 billion in General Revenue Funds and $0.3 billion in General Revenue–Dedicated Funds. These amounts represent an All Funds decrease of $1.8 billion, or 50.0 percent, and a decrease in General Revenue Funds of $107.9 million (Senate), or 17.4 percent and $133.1 (House) million or 21.5%.
HIGHLIGHTS
- Funding in both houses includes $126.8 million in Federal Funds for COVID-19 pandemic response in the 2022–23 biennium. This amount represents a decrease of $1.7 billion in Federal Funds and $50.0 million in General Revenue Funds transferred from the Health and Human Services Commission (HHSC) for COVID-19 pandemic response in the 2020–21 biennium.
- Senate Funding includes $475.6 million in All Funds and $130.0 million in General Revenue Funds for HIV/STD prevention, which represents an increase of $31.2 million in All Funds and $30.0 million in General Revenue Funds to address increasing costs and to maintain services in the Texas HIV Medication Program.
- House Funding includes $47.4 million in All Funds, including $32.1 million in General Revenue Funds and General Revenue– Dedicated Funds, for Data Center Services. This represents an increase of $19.9 million in All Funds, including $8.1 million in General Revenue Funds, for ongoing and increased costs following significant upgrades related to the infectious disease surveillance system
- House funding includes an increase of $5.4 million in General Revenue Funds to provide a system viability assessment for the information technology platform used for DSHS health registries.
- Senate funding includes an increase of $2.8 million in General Revenue–Dedicated Funds Account No. 341, Food and Drug Fee, and General Revenue–Dedicated Account No. 5024, Food and Drug Registration, to improve food safety licensure, inspection, and enforcement activities.
- Senate funding includes an increase of $1.2 million in General Revenue Funds and General Revenue–Dedicated Funds to improve the functionality of the online licensure and registration system for businesses regulated by DSHS.
- Senate and House Funding includes a decrease of $23.9 million in General Revenue Funds because onetime funding provided in the 2020– 21 biennium is not continued. These funds were provided for laboratory repair and renovation; Laboratory Information Management System upgrade; National Electronic Disease Surveillance System upgrade; vehicles; Texas Center for Infectious Disease repair and renovation; laboratory equipment; and onetime laboratory operating costs. Funding also represents a decrease of $29.0 million in funding from the Economic Stabilization Fund (Other Funds) because onetime funding provided in the 2020–21 biennium for an emergency generator for the laboratory and trauma capacity and response infrastructure is not continued.
- Senate funding includes reductions totaling $27.3 million in General Revenue Funds and General Revenue–Dedicated Funds for the 2022–23 biennium. The House provides $32.9 million in reductions. Both houses make these reductions to address associated initiatives identified by the agency including: $6.0 million for the Medical Child Abuse Resources and Education System; $4.6 million in administrative support services payments that DSHS makes to HHSC; and $4.0 million to remove the zoster (shingles) vaccine from the formulary for adult immunization.
- Senate funding includes changes in method of financing that reduce General Revenue Funds by $29.6 million and replace those funds with $7.4 million in General Revenue–Dedicated Funds and $22.3 million in Other Funds due to projected revenue and account balances. The House includes changes in method of financing that reduce General Revenue Funds by $32.0 million and replace those funds with $9.7 million in General Revenue–Dedicated Funds and $22.3 million in Other Funds due to projected revenue and account balances. These changes in both houses include replacing General Revenue Funds with $22.3 million from the Public Health Medicaid Reimbursements Account (Other Funds); $3.4 million from General Revenue–Dedicated Account No. 524, Public Health Services Fee; $2.3 million from General Revenue–Dedicated Account No. 129, Hospital Licensing (House only); $2.0 million from General Revenue–Dedicated Account No. 5108, EMS, Trauma Facilities, Trauma Care Systems; and $2.0 million from other General Revenue–Dedicated accounts.
***
The information contained in this publication is the property of Texas Insight. The views expressed in this publication are, unless otherwise stated, those of the author and not those of Texas Insight or its management.